| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9931765 | The Journal of Pain | 2005 | 5 Pages |
Abstract
Bone cancer pain can be severe and difficult to control fully. With a mouse model of bone cancer pain we demonstrate that pharmacologic blockade of the bradykinin B1 receptor is effective in reducing bone cancer pain-related behaviors, suggesting that B1 antagonists might be useful in attenuating bone cancer pain in humans.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Molly A. Sevcik, Joseph R. Ghilardi, Kyle G. Halvorson, Theodore H. Lindsay, Kazufumi Kubota, Patrick W. Mantyh,